18^th Global Pharmacovigilance & Clinical Trials Summit

Welcome

It is our great pleasure to warmly welcome pharmacovigilance professionals, clinical researchers, regulatory experts, healthcare professionals, pharmaceutical industry leaders, academicians, scientists, and technology innovators from around the world to the 18th Global Pharmacovigilance & Clinical Trials Summit. This international summit brings together a global community dedicated to advancing medicine safety, clinical research, regulatory science, and patient protection.

The summit provides an engaging platform for experts to exchange knowledge, present innovative research, and discuss the rapidly evolving landscape of pharmacovigilance, clinical trials, drug safety, regulatory affairs, real-world evidence, and digital healthcare. Participants will have opportunities to explore emerging technologies, evolving regulatory frameworks, advanced safety-monitoring approaches, and innovative clinical research methodologies.

We look forward to welcoming you to this distinguished scientific gathering in London, UK, where meaningful discussions, professional networking, research collaboration, and knowledge exchange can contribute to safer medicines and stronger clinical research practices.

About the Conference

The 18th Global Pharmacovigilance & Clinical Trials Summit is an international scientific forum focused on the latest developments in pharmacovigilance, clinical trials, drug safety, regulatory affairs, clinical research, and patient safety. The summit brings together professionals from academia, pharmaceutical and biotechnology companies, contract research organizations, regulatory bodies, healthcare institutions, and technology sectors.

The scientific program will explore emerging areas such as AI-driven pharmacovigilance, automated case processing, signal detection, real-world evidence, decentralized clinical trials, digital health, risk management, safety analytics, regulatory compliance, and post-marketing surveillance. The summit aims to encourage collaboration and knowledge sharing among professionals working across the medicine-development and safety lifecycle.

Why Attend the Conference

Attending the 18th Global Pharmacovigilance & Clinical Trials Summit offers an opportunity to stay updated on the latest developments in drug safety, clinical trials, pharmacovigilance, regulatory science, and clinical research. Participants can gain insights from experienced professionals and explore practical approaches to addressing current challenges in medicine safety and clinical development.

The summit also provides opportunities to present research, discover emerging technologies, build international professional networks, establish collaborations, exchange scientific knowledge, and connect with pharmaceutical, biotechnology, CRO, healthcare, and regulatory organizations. It is an ideal platform for professionals seeking to understand the future direction of clinical research and pharmacovigilance.

Target Audience

The 18th Global Pharmacovigilance & Clinical Trials Summit is designed for a diverse international audience involved in drug safety, clinical research, pharmacovigilance, regulatory affairs, healthcare, pharmaceuticals, biotechnology, and emerging health technologies. The summit welcomes professionals from academia, industry, regulatory organizations, research institutions, and healthcare sectors who are interested in advancing clinical research, medicine safety, and patient protection.

• Pharmacovigilance Professionals
• Clinical Researchers
• Clinical Trial Specialists
• Drug Safety Experts
• Regulatory Affairs Professionals
• Regulatory Scientists
• Pharmacologists
• Clinical Pharmacologists
• Physicians
• Healthcare Professionals
• Pharmaceutical Scientists
• Biotechnology Specialists
• CRO Professionals
• Medical Affairs Professionals
• Safety Physicians
• Medical Monitors
• Clinical Research Associates
• Clinical Research Coordinators
• Clinical Data Manager

Sections & Tracks

1. Pharmacovigilance

Pharmacovigilance focuses on the systematic monitoring, detection, assessment, and prevention of adverse effects associated with medicines. This track explores safety data collection, individual case safety reports, signal management, and risk evaluation. It also covers innovative approaches for strengthening medicine safety throughout the product lifecycle. Researchers can present new strategies for improving global pharmacovigilance practices and patient protection.

2. Clinical Trials

Clinical Trials focuses on the design, management, conduct, and evaluation of clinical studies. Topics include innovative trial designs, patient recruitment, clinical endpoints, trial monitoring, safety assessment, and data quality. The session explores modern approaches for improving trial efficiency, transparency, and patient participation. Researchers can share developments that support faster, safer, and more reliable clinical research.

3. Drug Safety

Drug Safety focuses on identifying, evaluating, monitoring, and managing potential risks associated with pharmaceutical products. This track covers adverse events, medication errors, safety assessments, benefit-risk evaluation, and safety communication. It explores strategies for detecting potential safety concerns at different stages of drug development. The session emphasizes patient protection and the responsible use of medicines.

4. Risk Management

Risk Management explores systematic approaches for identifying, evaluating, controlling, and minimizing risks associated with medicines. Topics include risk management plans, risk minimization measures, safety concerns, benefit-risk assessment, and regulatory expectations. The session highlights proactive methods for managing known and potential risks. Researchers can discuss innovative approaches to improving pharmaceutical risk management.

5. Signal Detection

Signal Detection focuses on identifying potential new safety concerns from clinical, spontaneous reporting, and real-world data sources. This track covers data mining, statistical analysis, signal validation, prioritization, and evaluation. Advanced technologies such as artificial intelligence and machine learning will also be explored. The session highlights methods for improving the accuracy and efficiency of safety-signal identification.

6. Clinical Research

Clinical Research explores scientific approaches for evaluating medicines, therapies, and healthcare interventions. This track covers research methodologies, clinical study design, translational research, patient-centered research, clinical outcomes, and research ethics. It provides a platform for sharing innovative research findings and practical experiences. The session emphasizes improving the quality, reliability, and impact of clinical research.

7. Regulatory Affairs

Regulatory Affairs focuses on the regulatory frameworks governing clinical trials, medicines, and pharmacovigilance activities. Topics include regulatory submissions, international guidelines, compliance requirements, inspections, safety documentation, and regulatory strategies. The track examines evolving global regulatory expectations and challenges. Participants can discuss approaches for maintaining compliance throughout the drug development lifecycle.

8. Real-World Evidence

Real-World Evidence explores the use of real-world data to evaluate the safety, effectiveness, and utilization of medicines. This track includes electronic health records, patient registries, observational studies, healthcare databases, and post-authorization research. Researchers can present innovative approaches for generating meaningful evidence outside traditional clinical trials. The session highlights the growing role of real-world evidence in healthcare and regulatory decision-making.

9. Safety Analytics

Safety Analytics focuses on applying statistical methods, data science, and advanced technologies to pharmaceutical safety information. Topics include predictive analytics, safety databases, data visualization, automated reporting, and large-scale safety-data analysis. The session explores methods for identifying patterns and emerging safety concerns. Researchers can present innovative analytical approaches for supporting evidence-based safety decisions.

10. Digital Health

Digital Health explores the use of digital technologies in clinical research, pharmacovigilance, and patient safety. This track covers mobile health, wearable devices, remote monitoring, electronic health systems, digital therapeutics, and virtual healthcare. Discussions will focus on how digital solutions can improve data collection, patient engagement, and safety monitoring. The session highlights emerging technologies transforming modern clinical research.

11. Artificial Intelligence

Artificial Intelligence focuses on the application of AI and machine learning in pharmacovigilance and clinical research. Topics include automated case processing, natural language processing, signal detection, predictive safety analytics, data classification, and intelligent decision-support systems. The track explores opportunities to improve efficiency and reduce manual processes. It also addresses data quality, transparency, validation, ethics, and regulatory considerations.

12. Clinical Data

Clinical Data focuses on the collection, organization, management, validation, and analysis of information generated during clinical studies. This track covers electronic data capture, clinical databases, data standards, data quality, data integrity, and data-management technologies. Researchers can discuss strategies for improving the reliability and accessibility of clinical information. The session highlights the importance of high-quality data in successful clinical research.

13. Patient Safety

Patient Safety focuses on preventing medication-related harm and improving healthcare quality and outcomes. Topics include medication errors, adverse events, patient reporting, safety communication, adherence, and patient involvement in safety monitoring. The session promotes patient-centered approaches to medicine safety. Researchers can explore innovative strategies for strengthening patient participation and reducing preventable risks.

14. Safety Surveillance

Safety Surveillance focuses on continuous monitoring of medicines and medical products throughout their lifecycle. This track covers post-marketing surveillance, adverse-event monitoring, epidemiological studies, long-term safety assessment, and safety databases. Researchers can discuss methods for identifying emerging risks and evaluating safety trends. The session highlights the importance of continuous monitoring in protecting patients and maintaining confidence in medicines.

15. Regulatory Compliance

Regulatory Compliance examines adherence to legal, ethical, quality, and regulatory requirements in clinical research and pharmacovigilance. Topics include audits, inspections, standard operating procedures, quality management systems, documentation, training, and compliance monitoring. The session explores best practices for maintaining regulatory standards. It also highlights strategies for reducing compliance risks and improving operational quality.